Dr Olayemi Olupitan is the Project Director of the Global Fund (GF) Grant Cycle 7 Tuberculosis/HIV project of the Institute of Human Virology Nigeria (IHVN). In this interview, she spoke on ways to ...

Researchers identified three new all-oral drug regimens that include at least one of two new drugs for treatment of ...

Introduction Globally, tuberculosis (TB) remains one of the leading infectious causes of death, with 1.3 million deaths.

HIV is spread by bodily fluids such as blood, breast milk or semen. It gradually weakens the body's immune system and makes ...

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.

According to the officials, the new regimen, called BPaL/BPaLM, includes medications bedaquiline, pretomanid, linezolid, and ...

A landmark review in Molecular Biomedicine outlines cutting-edge strategies to combat tuberculosis (TB), highlighting novel ...

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and into the lungs, the pathogen that causes "TB" can lead to chronic cough, ...

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and ...

and RR (rifampicin-resistant) tuberculosis and should be a focus for case-finding efforts,” the authors wrote. Rifampicin is a key drug recommended by the World Health Organisation as first-line ...

and RR (rifampicin-resistant) tuberculosis and should be a focus for case-finding efforts." Rifampicin is a key drug recommended by the World Health Organisation as a first-line treatment for TB.